Skip to main content
ONCIMMUNE HOLDINGS PLC logo

ONCIMMUNE HOLDINGS PLC — Investor Relations & Filings

Ticker · ONC ISIN · GB00BYQ94H38 LEI · 213800HCYIWT6YPI1I02 IL Professional, scientific and technical activities
Open in API
Filings indexed 362 across all filing types
Latest filing 2022-02-28 Regulatory Filings
Country GB United Kingdom
Listing IL ONC

About ONCIMMUNE HOLDINGS PLC

https://www.oncimmune.com/

Oncimmune Holdings PLC is a precision medicine and immunodiagnostics company specializing in the discovery and application of antibody and autoantibody biomarker signatures. The company's core technology is the ImmunoINSIGHTS™ platform, an advanced analytical engine for immune profiling. This platform utilizes a proprietary library of over 9,000 human antigens, bead-based multiplexed immunoassay technology, and machine learning algorithms to generate biological insights from minimal sample volumes. Oncimmune applies its expertise across therapeutic areas including immuno-oncology, autoimmune diseases, and infectious diseases. It provides biomarker discovery services, targeted panels, and advanced bioinformatics to support pharmaceutical and biotechnology partners in developing more effective and targeted treatments and diagnostics.

Recent filings

Filing Released Lang Actions
Contract signed with Verily Life Sciences
Regulatory Filings Classification · 98% confidence The document begins with 'RNS Number : 9424C' and is dated '28 February 2022'. It announces a commercial contract signing between Oncimmune Holdings PLC and Verily Life Sciences regarding COVID-19 autoantibody profiling. The text concludes with standard disclaimers and contact information typical of a regulatory news service announcement, specifically mentioning 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. This structure strongly indicates a general regulatory announcement that doesn't fit the more specific categories like 10-K, ER, or DIV. Therefore, the most appropriate classification is Regulatory Filings (RNS). The document length (6335 chars) is substantial enough that it is the primary announcement itself, not just a brief notice of publication (RPA).
2022-02-28 English
[change-account-reference-date-company-current-extended] made_up_date=2022-05-31, new_date=2022-08-31
Regulatory Filings
2022-02-28 English
Notice of Half Year Results
Report Publication Announcement Classification · 99% confidence The document is an RNS announcement (indicated by 'RNS Number : 7626C' and the closing statement referencing RNS) titled 'Notice of Half Year Results'. It explicitly states that the company 'will be announcing its half year results for the six months ended 30 November 2021 on 28 February 2022.' Furthermore, it details an accompanying analyst and investor presentation via Investor Meet Company. Since this document is an announcement *about* the upcoming release of the half-year results, and not the comprehensive results document itself (which would likely be classified as IR - Interim Report), it fits the definition of a Report Publication Announcement (RPA). The document is short and serves to inform the market about the publication date and associated events.
2022-02-25 English
Holding(s) in Company
Major Shareholding Notification Classification · 99% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains fields detailing the 'Identity of the issuer', 'Reason for the notification' (specifically 'An acquisition or disposal of voting rights'), and the 'Total positions of person(s) subject to the notification obligation' regarding voting rights percentages (6.057788%). This structure is characteristic of regulatory filings concerning changes in significant share ownership thresholds. This directly matches the definition for Major Shareholding Notification (MRQ). Although it is distributed via RNS, the core content is a specific regulatory disclosure form, making MRQ the most precise classification over the general RNS fallback.
2022-02-21 English
EarlyCDT Lung approved and adopted in Aragon Spain
Regulatory Filings Classification · 100% confidence The document is clearly identified as an RNS announcement (RNS Number : 9299B) distributed via 'Reach', which is explicitly stated to be a non-regulatory press release distribution service. The content is a news update regarding the approval and adoption of the company's EarlyCDT Lung test in Aragon, Spain. This type of general corporate news update, especially when distributed via a non-regulatory channel like 'Reach' and not fitting into specific categories like ER, CAP, or DIV, falls best under the general regulatory/news announcement category. Since it is a general announcement that doesn't fit the specific definitions (like 10-K, ER, CT, etc.), the most appropriate fallback is Regulatory Filings (RNS), as it is a formal notification to the market, even if designated as 'non-regulatory' by the distributor.
2022-02-17 English
ImmunoINSIGHTS commercial update
Regulatory Filings Classification · 100% confidence The document begins with an 'RNS Number' and is dated, indicating it is a regulatory announcement distributed via the RNS service of the London Stock Exchange. The content details a commercial update, specifically a new contract signed under an existing Master Services Agreement (MSA) and the establishment of a new office. This type of operational and commercial news release, which is not a full financial report (like 10-K or IR), a specific voting result (DVA), or a director's dealing (DIRS), fits best under the general category for regulatory announcements that don't fit elsewhere, or potentially an Earnings Release (ER) if it were summarizing results. Since it is a specific commercial update announced via RNS, and the document structure strongly suggests a standard regulatory news service release, the most appropriate classification is Regulatory Filings (RNS), which serves as the general category for such announcements.
2022-02-15 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.